Perioperative Interdisciplinary, Intersectoral Process Optimization in Heart Failure
PeriOP-CARE HF
1 other identifier
interventional
1,057
1 country
1
Brief Summary
Chronic heart failure affects up to three million people in Germany, with prevalence increasing with age. It is a leading cause of cardiovascular disease-related deaths. Patients with heart failure undergoing non-cardiac surgery face higher risks of complications and death compared to those with coronary artery disease. Despite guidelines recommending comprehensive preoperative evaluation, there is no systematic risk assessment structure in place, leading to inadequate perioperative care. This study aims to evaluate a multidisciplinary approach for high-risk patients aged 65 and above, regardless of prior heart failure diagnosis, to mitigate postoperative complications. The investigators measure the NTpro BNP before surgery and include patients with NTproBNP\> 450 in this study and randomize them either to the standard care group or the intervention group.The hypothesis is that standardized risk screening and multidimensional care (Intervention group) can reduce complications in these patients undergoing non-cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable heart-failure
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2024
CompletedFirst Posted
Study publicly available on registry
April 24, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
March 3, 2025
February 1, 2025
2 years
February 26, 2024
February 26, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
combined primary endpoint at 90 days post-operation : re-hospitalization,AKI, bacterial infection and cardiac decompensation
The combined primary endpoint at 90 days post-operation consists of re-hospitalization for any reason, acute kidney injury according to KDIGO definition, any bacterial infection, and cardiac decompensation.
90 days post-operation
Secondary Outcomes (9)
Incidence of acute kidney injury
at 30 and 90 days
Incidence of any, treatable, suspected, or confirmed bacterial infection
at 30 and 90 days
Incidence of cardiac decompensation
at 30 and 90 days
Incidence of re-hospitalization
at 30 and 90 days
Mortality
at 30 and 90 days
- +4 more secondary outcomes
Other Outcomes (1)
Utilization of services and costs
during the intervention at the hospital
Study Arms (2)
Standard group
NO INTERVENTIONIn this group, the anesthesiological risk evaluation is generally conducted in accordance with the current guidelines. Possible additional (instrumental) examinations, intraoperative anesthesiological management, and postoperative inpatient therapy are carried out according to current guidelines and are unaffected by study participation. If services are provided in the control group within the local standards that are also part of the new care model, these will be documented to ensure comparability.
Intervention group
ACTIVE COMPARATORA cardiology consultation is conducted, which includes a standardized evaluation. This includes, medical history and physical examination:ECG, Echocardiography, Determination of cardiac troponins and natriuretic peptides in the local central laboratory. The echocardiography aims to qualitatively and quantitatively describe the left and right ventricular systolic and diastolic dimensions and function, as well as the valvular apparatus, the collected findings are presented at the interdisciplinary and intersectoral preoperative medical (POM) conference. Bedside visits with the patient are also possible.During this conference, structured preoperative interdisciplinary and intersectoral case discussions take place, involving the attending outpatient physicians. The POM conference consists of Anesthesiology, Cardiologist, Treating surgeon and optimize preoperative therapy and plan further pre-, intra-, and postoperative as well as outpatient care.
Interventions
Interdisciplinary decision-making for perioperative care involving a cardiologist, anesthesiologist, and surgeon in collaboration with the primary care physician. Decisions include determining whether surgery is feasible or if patient optimization is necessary first. Subsequently, targeted postoperative visits by a heart failure nurse and appropriate postoperative care, also after discharge from the hospital, through the primary care physician.
Eligibility Criteria
You may qualify if:
- Age ≥ 65 years
- Elective non-cardiac surgical operation with intermediate or high operative risk under general anesthesia or combined anesthesia (general and regional anesthesia) as per Figure 1
- ASA (American Society of Anesthesiologists) grade ≥ II
- Qualification for randomization: NT-proBNP ≥ 450pg/ml during routine preoperative evaluation and anesthesia consultation.
You may not qualify if:
- Age \< 65 years
- Cardiac surgery and cardiology interventional procedures
- Transplantation surgery (e.g., kidney, liver, lung transplantation)
- Kidney surgery (e.g., nephrectomy, partial nephrectomy)
- Procedures involving cardiopulmonary bypass
- Emergency surgery
- Surgery under general anesthesia within the last 30 days
- Primary use of local or regional anesthesia
- Chronic kidney insufficiency with eGFR \< 15 ml/min or dialysis-dependent kidney insufficiency
- Surgical time \< 30 minutes
- Participation in another interventional study
- Lack of consent
- Limited language proficiency
- Patient's limited or absent capacity to provide consent, as well as patients under legal guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Giessenlead
- Deutsche Luft und Raumfahrtcollaborator
Study Sites (1)
Justus Liebig University Giessen, University Hospital Giessen and Marburg
Giessen, 35390, Germany
Related Publications (1)
PeriOP-CARE HF study group. Perioperative interdisciplinary optimisation of patients with heart failure undergoing non-cardiac surgery with intermediate or high surgical risk: the rationale and study protocol for the multicentre, randomised interventional PeriOP-CARE HF trial. Clin Res Cardiol. 2025 May;114(5):523-531. doi: 10.1007/s00392-025-02626-3. Epub 2025 Apr 29.
PMID: 40299034DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2024
First Posted
April 24, 2024
Study Start
September 1, 2024
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
March 3, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share